Core Laboratories Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Shareholders held by Core Laboratories Inc. on May 21, 2025, in Houston, Texas. The filing was submitted on May 27, 2025, by Christopher S. Hill, Chief Financial Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Shareholders approved all three proposals presented at the Annual Meeting. More than 50% of the issued share capital was present or represented. The certified results are as follows:
- Proposal 1 (Election of Class II Directors): Approved.
- Martha Z. Carnes: 37,510,862 For; 2,818,729 Withheld.
- Katherine Murray: 39,747,197 For; 582,394 Withheld.
- Rob Martinovich: 38,894,796 For; 1,434,795 Withheld.
- Proposal 2 (Ratification of KPMG LLP): Approved.
- For: 41,812,461; Against: 685,311; Abstentions: 14,051.
- Proposal 3 (Advisory Vote on Executive Compensation): Approved.
- For: 38,010,404; Against: 2,292,675; Abstentions: 26,512.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of shareholder voting outcomes.
Key Facts for Investor Verification
- Verify the full proxy statement for details on the Compensation Discussion and Analysis (CD&A) referenced in Proposal 3.
- Confirm the tenure and specific responsibilities of the newly elected and re-elected Class II Directors (Carnes, Murray, Martinovich).
- Review the upcoming 10-K or 10-Q filings for the financial metrics absent from this 8-K.